BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang S, Huang Z, Jiang J, Gao J, Zhao C, Tai Y, Ma X, Zhang L, Ye Y, Gan C, Su W, Jia X, Liu R, Wu H, Tang C. Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in rats. Life Sci 2021;272:119203. [PMID: 33577848 DOI: 10.1016/j.lfs.2021.119203] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Senousy SR, El-Daly M, Ibrahim ARN, Khalifa MMA, Ahmed AF. Effect of Celecoxib and Infliximab against Multiple Organ Damage Induced by Sepsis in Rats: A Comparative Study. Biomedicines 2022;10:1613. [PMID: 35884918 DOI: 10.3390/biomedicines10071613] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gan C, Cai Q, Tang C, Gao J. Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis. Front Immunol 2022;13:896473. [DOI: 10.3389/fimmu.2022.896473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kronborg TM, Ytting H, Hobolth L, Møller S, Kimer N. Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study. Front Med (Lausanne) 2021;8:718896. [PMID: 34631742 DOI: 10.3389/fmed.2021.718896] [Reference Citation Analysis]